CNBC May 25, 2024
Key Points
– Some analysts estimate that anti-obesity medications could grow into a $100 billion industry by the end of the decade.
– Companies including Calibrate, Ro and WeightWatchers are looking to capitalize on the GLP-1 boom by launching weight loss programs around medications like Ozempic and Wegovy.
– Medication shortages, spotty insurance coverage and counterfeits have created challenges for companies and consumers.
For Gray Beard, a kindergarten teacher in Charlotte, North Carolina, losing weight had become a grueling task. She’d tried five different programs in her life and never found lasting results.
Her luck started to change last year, when she saw a promotion on Instagram for the Ro Body Program, a new offering from online health startup Ro....
Today's Sponsors
Today's Sponsor